| Basic data
|
| (21) | Request Number: | S20190019A (Supplementary Protection Certificate granted) |
| (22) | Request Date: | 17.05.2019 |
| (43) | Request Publication Date: | 14.06.2019 |
| |
| (71) | Applicant(s): | | 1. | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP |
|
| (74) | Representative: | CPZ - CENTAR ZA PATENTE d.o.o.,
Kutinska 2, 10000 Zagreb, HR
|
| |
| (68) | Basic Patent Number: | P20171534 |
| (21) | Application Number | P20171534A |
| (22) | Filing Date | 11.10.2017 |
| (54) | Title of Invention: | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS |
| |
| (95) | Product Name: | BRIGATINIB, ILI NJEGOVA FARMACEUTSKI PRIHVATLJIVA SOL |
| |
| (92)(93) | Number and Date of First Marketing Authorisation: | |
| |
| (11) | SPC Number: | S20190019 |
| | Date of Grant: | 21.05.2025 |
| | Publication Date: | 06.06.2025 |
| (94) | Validity Period: | 22.05.2029 - 26.11.2033 |
| |
| | | TRANSFER | | New entry: | Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
| | Previous entry: | ARIAD PHARMACEUTICALS, INC.,
40 Landsdowne Street, Cambridge, MA 02139, US
| | | Recording date: | 22.10.2021 | | | Publication date: | 29.10.2021 | |
|